南方明晟A50截至二零二五年十二月三十一日止的經審核賬目

CSOP STAR 50 INDEX ETFStock Code:3109 CSOP HUATAI-PINEBRIDGE CSIPHOTOVOLTAIC INDUSTRY ETFStock Code:3134 CSOP HANG SENG BIOTECH ETF (formerly known as CSOP CHINAHEALTHCARE DISRUPTION INDEX ETF)Stock Code:3174 CSOP MSCI CHINA A 50 CONNECT ETFStock Code: 3003 CSOP NASDAQ 100 ETFStock Code: 3034 CSOP ETF SERIES OFC(An umbrella open-ended fund company established under the laws of Hong Kong) CONTENTSPages Report of the custodian to the shareholders1Independent auditor's report2-11Audited financial statementsStatement of net assets12-13Statement of profit or loss and other comprehensive income14-17Statement ofchanges in net assets attributable to shareholders18-21Statement of changes inequity22Statement of cash flows23-25Notes to the financial statements26-93Investment portfolio (Unaudited)94-113Statement of movements ininvestment portfolio (Unaudited)114-128Holdings of collateral (Unaudited)129-130Performance record (Unaudited)131–136Details in respect of swap fees for financial derivative instruments (Unaudited)137Management andadministration138 CSOP ETF SERIES OFC(An umbrella open-ended fund company established under the laws of Hong Kong) REPORT OF THECUSTODIANTO THESHAREHOLDERS We hereby confirm that, in our opinion,CSOP Asset ManagementLimited, the Manager ofCSOPETF SeriesOFC(the"Company"),has, in all material respects, managed theCompany,in accordance with the provisionsof theOFC's instrument of incorporation. For the year ended31December2025: 1.CSOP STAR 50 Index ETF 2.CSOP Huatai-PineBridge CSI Photovoltaic Industry ETF 3.CSOPHang Seng Biotech ETF (formerly known asCSOP China Healthcare Disruption Index ETF) 4.CSOP MSCI China A 50 Connect ETF 5.CSOP NASDAQ 100 ETF 6.CSOP FTSEVietnam30 ETF Cititrust Limited (the"Custodian")28 April2026 To the shareholders ofCSOP ETF Series OFC (the"Company") and CSOP STAR 50 Index ETF, CSOPHuatai-PineBridge CSI Photovoltaic Industry ETF, CSOPHang Seng Biotech ETF (formerly knownasCSOP China Healthcare Disruption Index ETF), CSOP MSCI China A 50 Connect ETF, CSOPNASDAQ 100 ETFand CSOP FTSE Vietnam 30 ETF (collectively the"Sub-Funds") of the Company(An umbrella open-ended fund company established under the laws of Hong Kong) Report on the Audit of the Financial Statements Opinion We have audited the financial statements of CSOP ETF Series OFC (the"Company") and its sub-funds,namely CSOP STAR 50 Index ETF, CSOP Huatai-PineBridge CSI Photovoltaic Industry ETF,CSOPHangSeng Biotech ETF (formerly known asCSOP China Healthcare Disruption Index ETF), CSOP MSCI ChinaA 50 Connect ETF,CSOP NASDAQ 100 ETFand CSOP FTSE Vietnam 30 ETF for the year ended31December2025(each a separate sub-fund of the Company and referred to as"Sub-Funds") set out on pages12to93, which comprise the statement of net assets of the Company and Sub-Funds as at 31 December2025,and the statement of profit or loss and other comprehensive income, the statement of changes in net assetsattributable to shareholders and statement of changes in equity of the Company and each of the Sub-Fund andstatement of cash flows of the Sub-Funds for the year then ended, and notes to the financial statements,including material accounting policy information. In our opinion, the financial statements give a true and fair view of the financial position of the Company andthe Sub-Funds as at 31 December2025, and of each of their financial performance and cash flows for the yearthen ended in accordance with IFRS Accounting Standards as issued by the International AccountingStandards Board (IASB). Basis for Opinion We conducted our audit in accordance with International Standards on Auditing ("ISAs").Our responsibilitiesunder those standards are further described in theAuditor's Responsibilities for the Audit of the FinancialStatements sectionof our report. We are independent of theCompany and theSub-Fundsin accordance withHong Kong Institute of Certified Public Accountants’Code of Ethics for Professional Accountants(the"Code"),as applicableto audits of financial statements of public interest entities.We have also fulfilled ourother ethical responsibilities in accordance with the Code. We believethat the audit evidence we have obtainedis sufficient and appropriate to provide a basis forour opinion. Key Audit Matters Key audit matters are those matters that, in our professional judgement, were of most significance in our auditof the financial statements of the current period. These matters were addressed in the context of our audit ofthe financial statements as a whole, and in forming our opinion thereon, and we do not provide a separateopinion on these matters. For each matter below, our description of how our audit addressed the matter isprovided in that context. We have fulfilledthe responsibilities described in theAuditor's responsibilities for the audit of the financialstatementssection of our report, including in relation to these matters. Accordingly, our audit included theperformance of procedures design